# Journal of hematology & oncology

Source: https://onco.cc/journals/journal-of-hematology-and-oncology/  
OnCo record `journal-of-hematology-and-oncology` (Journal). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A large open access journal spanning blood cancers and solid tumours, from laboratory mechanisms to clinical trials. Read by haematologists, oncologists and translational researchers.

## Summary

The journal is published by BMC, part of Springer Nature, and describes itself as an open access journal publishing top-quality research encompassing all aspects of haematology and oncology, serving as an international platform for sharing laboratory and clinical findings among laboratory scientists, physician scientists, haematologists and oncologists. It publishes research articles, reviews and research highlights on topical subjects from leading experts. NLM catalogues it from 2008 as a free open access electronic journal published by BioMed Central, noting that as an online journal it has no issue numbers and each volume corresponds to a calendar year. The Directory of Open Access Journals lists it as open access since 2008 with anonymous peer review, an article processing charge, and CC BY and CC BY-NC-ND licences.

## Fields

- Kind: Journal
- Last checked: 2026-09-10
- Also known as: J Hematol Oncol; JHO
- Publisher: BMC (Springer Nature)
- Scope: haematological oncology and oncology
- Access: open-access

## Sources

- Homepage: https://jhoonline.biomedcentral.com/
- NLM Catalog: https://www.ncbi.nlm.nih.gov/nlmcatalog/101468937
- DOAJ record: https://doaj.org/toc/1756-8722

## Connected records

- collections: [PubMed & Europe PMC](https://onco.cc/collections/pubmed-europepmc/)
- cancers: [Acute myeloid leukaemia](https://onco.cc/cancers/aml/), [Chronic lymphocytic leukaemia](https://onco.cc/cancers/cll/), [Multiple myeloma](https://onco.cc/cancers/multiple-myeloma/)
- people: [Lim Soon Thye](https://onco.cc/people/lim-soon-thye/), [Yu Jinming](https://onco.cc/people/yu-jinming/), [Yuquan Wei](https://onco.cc/people/wei-yuquan/)
- key papers: [A phase 1, open-label study of LCAR-B38M, a chimeric antigen receptor T cell therapy directed against B cell maturation antigen, in patients with relapsed or refractory multiple myeloma](https://onco.cc/key-papers/paper-zhao-j-hematol-oncol/), [PACIFIC-5: a phase III clinical trial of consolidation durvalumab in patients with unresectable stage III NSCLC and no progression after concurrent or sequential chemoradiotherapy](https://onco.cc/key-papers/paper-nct03706690-j-hematol-oncol-2025/), [Results of a phase 1/2 study of sacituzumab tirumotecan in patients with unresectable locally advanced or metastatic solid tumors refractory to standard therapies](https://onco.cc/key-papers/paper-nct04152499-j-hematol-oncol-2025/)

---
JSON: https://onco.cc/api/v1/entities/journal-of-hematology-and-oncology.json